OS Therapies Incorporated
OSTX
$2.50
$0.177.30%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.28M | -11.30M | -8.88M | -7.36M | -6.46M |
| Total Depreciation and Amortization | 114.60K | 2.80K | 2.80K | 1.40K | 4.70K |
| Total Amortization of Deferred Charges | 338.30K | 1.43M | 1.43M | 1.64M | 2.28M |
| Total Other Non-Cash Items | 1.65M | 456.60K | 301.80K | 0.00 | 0.00 |
| Change in Net Operating Assets | 616.90K | -666.90K | -129.80K | -63.00K | 898.90K |
| Cash from Operations | -11.56M | -10.08M | -7.28M | -5.78M | -3.27M |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -466.40K | -173.60K | -- | 0.00 | 0.00 |
| Cash from Investing | -466.40K | -173.60K | -- | 0.00 | 0.00 |
| Total Debt Issued | 0.00 | 900.00K | 1.75M | 2.82M | 3.65M |
| Total Debt Repaid | -250.00K | -250.00K | -250.00K | -250.00K | -- |
| Issuance of Common Stock | 5.23M | 5.23M | 5.23M | 5.23M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 7.10M | 7.10M | 6.05M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.66M | 148.00K | 0.00 | -175.90K | -329.60K |
| Cash from Financing | 14.74M | 13.13M | 12.78M | 7.62M | 3.32M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.71M | 2.87M | 5.49M | 1.84M | 45.60K |